HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical events following neuroangiography: a prospective study.

Abstract
Clinical events following cerebral angiography were prospectively evaluated in 1,002 procedures. The ischemic event rate between 0 and 24 hours was 1.3% (0.1% permanent). This incidence was higher (2.5%) in patients investigated for cerebrovascular disease, but the difference was not significant. In addition, 1.8% of the patients suffered ischemia (0.3% permanent) between 24 and 72 hours after angiography. Cerebral ischemic events occurred as a recurrence or worsening of a preexisting phenomenon. twice as often as de novo. All permanent ischemia was a worsening of a preexisting phenomenon. There was a significant increase in the incidence of neurologic events between 0 and 24 hours when the procedure lasted longer than 60 minutes and when there was systolic hypertension. Trends toward higher incidence were noted with the use of increased volume of contrast, with increased serum creatinine, when transient ischemic attacks or stroke were the indications, and when 3 or more catheters were used. The incidence of neurologic events between 24 and 72 hours increased significantly with the increase in the amount of contrast used, with age, and with diabetes. The occurrence of nonneurologic events (mostly hematomas) was significantly increased by multiple factors. This study shows that events can and do occur beyond the usual observation period of 24 hours but confirms the low risk of cerebral angiography when performed judiciously.
AuthorsJ E Dion, P C Gates, A J Fox, H J Barnett, R J Blom
JournalStroke (Stroke) 1987 Nov-Dec Vol. 18 Issue 6 Pg. 997-1004 ISSN: 0039-2499 [Print] United States
PMID3686597 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Contrast Media
Topics
  • Age Factors
  • Brain Ischemia (etiology)
  • Cerebral Angiography (adverse effects)
  • Cerebral Hemorrhage (etiology)
  • Cerebrovascular Disorders (etiology)
  • Contrast Media (administration & dosage)
  • Diabetes Complications
  • Female
  • Humans
  • Hypertension (complications)
  • Ischemic Attack, Transient (etiology)
  • Male
  • Prospective Studies
  • Risk Factors
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: